Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spinal disc. The company's first product, DiscCell, is an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc.